期刊文献+

肠微生态移植重建治疗重度银屑病的临床研究 被引量:7

Fecal microbiota transplantation as a novel therapy for severe psoriasis
原文传递
导出
摘要 通过肠微生态移植重建(FMT)治疗重度银屑病,探索治疗银屑病的新方法.患者男,36岁,患寻常型银屑病10年,肠易激综合征15年,进行2次胃、肠镜联合FMT治疗.评估治疗前后皮损累及体表面积(BSA)、银屑病面积和严重程度指数(PASI)、生活质量指数(DLQI)、皮肤组织病理、肠道症状、安全性及血清肿瘤坏死因子α等.结果显示,FMT治疗该例银屑病患者临床疗效显著,肠易激综合征临床症状消失,且无不良反应发生.提示FMT可能是治疗银屑病的一种新疗法,值得进一步研究. [Summary] To explore the therapeutic effect of fecal microbiota transplantation (FMT) for severe psoriasis. A patient, male, 36 years old, diagnosed as severe plaque psoriasis for 10 years and irritable bowel syndrome (IBS) for 15 years, was administrated twice FMT via both upper endoscopy and colonoscopy with a 5‐week interval. The following items were used to evaluate responses: body surface area (BSA), psoriasis area and severity index (PASI), dermatology life quality index (DLQI), histological examination, intestinal symptoms, adverse reactions and serum level of tumor necrosis factor (TNF)‐α. After second FMT treatment for 5 weeks, aforementioned items were improved greatly compared with those before treatment. Moreover, IBS was completely relieved and no adverse reactions were observed during the treatment and follow‐up. In conclusion, FMT could be a novel therapy for psoriasis. Further clinical trials are needed to provide solid evidences.
作者 殷广 李剑锋 孙玉发 丁潇 曾嘉琦 张婷 彭丽华 杨云生 赵华 Yin Guang;Li Jianfeng;Sun Yufa;Ding Xiao;Zeng Jiaqi;Zhang Ting;Peng Lihua;Yang Yunsheng;Zhao Hua(Department of Dermatology,Chinese PLA General Hospital,Chinese PLA Medical College,Beijing 100853,China;Department of Gastroenterology and Hepatology,Chinese PLA General Hospital,Chinese PLA Medical College,Beijing 100853,China;Department of Health Care,Chinese PLA Joint Staff Headquarters Guard Bureau,Beijing 100017,China;Training Department,Chinese PLA General Hospital,Beijing 100853,China)
出处 《中华内科杂志》 CAS CSCD 北大核心 2019年第10期782-785,共4页 Chinese Journal of Internal Medicine
关键词 肠微生态移植重建 银屑病 肠易激综合征 Fecal microbiota transplantation Psoriasis Irritable bowel syndrome
  • 相关文献

参考文献5

二级参考文献33

  • 1Zhang F, Luo W, Shi Y, et al. Should we standardize the 1,700-year-old fecal microbiota transplantation [ J ] .9 Am J Gastroenterol, 2012, 107 (11) : 1755.
  • 2Eiseman B, Silen W, Bascom GS, et al. Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis[ J]. Surgery, 1958, 44 (5) : 854-859.
  • 3Gough E, Shaikh H, Manges AR. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection [ J 1- Clin Infect Dis, 2011, 53 (10): 994-1002.
  • 4Anderson JL, Edney RJ, Whelan K. Systematic review: faecal microbiota transplantation in the management of inflammatory bowel disease [ J ]. Aliment Pharmacol Ther, 2012, 36 (6) : 503-516.
  • 5Brandt LJ, Aroniadis OC, Mellow M, et al. Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection [ J ]. Am J Gastroenterol, 2012, 107 (7): 1079-1087.
  • 6Surawicz CM, Brandt LJ, Binion DG, et al. Guide|ines for diagnosis, treatment, and prevention of Clostridium difficile infections [ J ~. Am J Gastroenterol, 2013, 108 (4) : 478-498.
  • 7van Nood E, Vrieze A, Nieuwdorp M, et al. Duodenal.infusion of donor feces for recurrent Clostridium difficile [J]. N Engl J Med, 2013, 368 (5) : 407-415.
  • 8Louie TJ, Miller MA, Mullane KM, et al; OPT-80-O03 Clinical Study Group. Fidaxomicin versus vancomycin for Clostridium difficile infection [ J ]. N Engl J Med, 2011, 364 (5) : 422-431.
  • 9Bennet JD, Brinkman M. Treatment of ulcerative colitis by implantation of normal colonic flora [ J ]. Lancet, 1989, 1 (8630) : 164.
  • 10Borody TJ, Warren EF, Leis S, et al. Treatment of ulcerative colitis using fecal bacteriotherapy [ J ]. J Clin Gastroenterol, 2003, 37 (1) : 42-47.

共引文献68

同被引文献48

引证文献7

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部